Profound Accounts Payable vs Other Stockholder Equity Analysis
PRN Stock | CAD 11.72 0.22 1.84% |
Profound Medical financial indicator trend analysis is much more than just breaking down Profound Medical Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Profound Medical Corp is a good investment. Please check the relationship between Profound Medical Accounts Payable and its Other Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Accounts Payable vs Other Stockholder Equity
Accounts Payable vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Profound Medical Corp Accounts Payable account and Other Stockholder Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Profound Medical's Accounts Payable and Other Stockholder Equity is 0.73. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Profound Medical Corp, assuming nothing else is changed. The correlation between historical values of Profound Medical's Accounts Payable and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Profound Medical Corp are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Accounts Payable i.e., Profound Medical's Accounts Payable and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Accounts Payable
An accounting item on the balance sheet that represents Profound Medical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Profound Medical Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Other Stockholder Equity
Most indicators from Profound Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Profound Medical's Selling General Administrative is very stable compared to the past year. As of the 29th of June 2024, Sales General And Administrative To Revenue is likely to grow to 1.63, though Tax Provision is likely to grow to (121.6 K).
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 303K | 174K | 770K | 718.0K | Depreciation And Amortization | 1.9M | 4.1M | 4.7M | 5.0M |
Profound Medical fundamental ratios Correlations
Click cells to compare fundamentals
Profound Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Profound Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 29.9M | 104.6M | 86.8M | 64.4M | 43.9M | 46.2M | |
Short Long Term Debt Total | 10.9M | 1.7M | 1.4M | 8.2M | 9.5M | 5.7M | |
Other Current Liab | 530.0K | 757K | 248K | 919K | 1.1M | 703.0K | |
Total Current Liabilities | 8.2M | 4.8M | 4.2M | 4.2M | 6.4M | 5.1M | |
Total Stockholder Equity | 14.3M | 97.4M | 80.6M | 52.0M | 31.2M | 36.2M | |
Property Plant And Equipment Net | 2.2M | 2.3M | 1.9M | 1.7M | 1.5M | 1.4M | |
Net Debt | (3.8M) | (82.2M) | (65.8M) | (38.3M) | (34.5M) | (36.2M) | |
Retained Earnings | (100.3M) | (130.0M) | (160.7M) | (189.4M) | (217.9M) | (207.0M) | |
Accounts Payable | 3.0M | 3.4M | 3.2M | 2.0M | 3.3M | 2.7M | |
Cash | 14.7M | 83.9M | 67.2M | 46.5M | 26.2M | 32.4M | |
Cash And Short Term Investments | 14.7M | 83.9M | 67.2M | 46.5M | 53.5M | 33.7M | |
Net Receivables | 3.3M | 7.4M | 1.4M | 6.3M | 6.8M | 3.6M | |
Common Stock Total Equity | 98.4M | 120.9M | 130.3M | 211.5M | 243.3M | 255.4M | |
Common Stock Shares Outstanding | 11.1M | 17.3M | 20.5M | 20.8M | 21.4M | 12.5M | |
Liabilities And Stockholders Equity | 29.9M | 104.6M | 86.8M | 64.4M | 74.1M | 46.0M | |
Other Current Assets | 1.0M | 1.1M | 1.1M | 1.2M | 1.4M | 1.5M | |
Other Stockholder Equity | 15.0M | 11.3M | 17.0M | 18.7M | 21.5M | 22.6M | |
Total Liab | 15.6M | 7.3M | 6.2M | 12.4M | 12.7M | 10.1M | |
Property Plant And Equipment Gross | 2.9M | 2.3M | 1.9M | 1.7M | 4.8M | 5.0M | |
Total Current Assets | 22.7M | 97.7M | 77.1M | 62.0M | 41.9M | 41.4M | |
Accumulated Other Comprehensive Income | (89.7K) | 4.6M | 4.7M | 16.8M | 19.4M | 20.3M | |
Short Term Debt | 4.1M | 312K | 250K | 762K | 685.8K | 1.2M | |
Intangible Assets | 2.4M | 1.9M | 1.4M | 680K | 490K | 465.5K | |
Common Stock | 99.7M | 211.5M | 219.6M | 205.8M | 236.7M | 124.1M | |
Other Liab | 654K | 1.1M | 875K | 764K | 878.6K | 1.1M | |
Net Tangible Assets | 9.3M | 92.8M | 76.5M | 51.3M | 59.0M | 38.9M | |
Non Current Assets Total | 7.2M | 6.9M | 9.7M | 2.4M | 2.0M | 1.9M | |
Long Term Debt | 10.6M | 6.7M | 0.0 | 6.7M | 5M | 5.3M | |
Long Term Debt Total | 8.8M | 1.4M | 1.1M | 7.5M | 8.6M | 5.4M | |
Non Current Liabilities Total | 7.4M | 2.4M | 2.0M | 8.2M | 6.4M | 5.5M | |
Capital Surpluse | 19.6M | 11.3M | 17.0M | 18.7M | 21.5M | 13.0M | |
Short Long Term Debt | 4.7M | 1.3M | 5.1M | 523K | 2.1M | 2.7M | |
Property Plant Equipment | 2.2M | 2.3M | 1.9M | 1.7M | 2.0M | 1.7M | |
Current Deferred Revenue | 501.2K | 358K | 477K | 471K | 541.7K | 380.5K | |
Inventory | 3.6M | 5.3M | 7.4M | 7.9M | 7.0M | 4.9M | |
Net Invested Capital | 23.4M | 97.4M | 80.6M | 59.2M | 38.3M | 53.8M | |
Net Working Capital | 14.5M | 92.9M | 73.0M | 57.8M | 35.5M | 47.3M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Profound Stock
When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.